The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

5 Mar 2020 09:21

RNS Number : 1288F
Jardine Matheson Hldgs Ltd
05 March 2020
 

Jardine Matheson Holdings Limited

Directorate Change

 

Jardine Matheson Holdings Limited (the 'Company') announces that, with effect from 15th June 2020, the roles of Executive Chairman and Managing Director, which have been held on a combined basis by Ben Keswick since December 2018, will revert to being separate roles.

 

Ben Keswick will remain as Executive Chairman and John Witt, currently Group Finance Director, will take on the role of Managing Director.

 

John joined Jardines in 1993 and held a range of senior roles across the Group's core businesses and geographies, including as chief financial officer of Hongkong Land and Mandarin Oriental, before being appointed to the Jardine Matheson Board in 2016.

 

John will also be a director of Jardine Strategic Holdings Limited and the Group's listed subsidiaries, Hongkong Land Holdings Limited, Dairy Farm International Holdings Limited and Mandarin Oriental International Limited. He will also continue to be a commissioner of Astra and chairman of the Astra Excom.

 

Graham Baker will replace John as Group Finance Director and will join the Group on 1st June 2020 from Smith + Nephew in the United Kingdom, where he has been a board member and chief financial officer since March 2017. Graham will join the Board of the Company.

 

Prior to joining Smith + Nephew, Graham worked for 20 years for AstraZeneca PLC in a range of senior roles in the UK and internationally, including in Japan and Singapore, and then as chief financial officer of generic pharmaceuticals company Alvogen.

 

Commenting on the changes, Ben Keswick said:

"I am confident that these appointments will strengthen and enhance the effectiveness of the Group's leadership as we respond to the challenges and opportunities we face in positioning Jardines for continuing long term success."

 

- end -

 

For further information please contact

 

Investor enquries:

Jonathan Lloyd

Jardine Matheson Limited

 

(852) 2843 8223

 

Media enquiries:

Brunswick

Tom Burns

 

(44) 207 404 5959

David Ashton

(852) 3512 5063

 

This and other Group announcements can be accessed at www.jardines.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUPUBAWUPUURA
Date   Source Headline
8th Nov 20169:19 amRNSJC&C 2016 Third Quarter Financial Statements
31st Oct 201610:05 amRNSTotal Voting Rights
31st Oct 20169:54 amRNSPT Astra - 2016 Third Quarter Financial Statements
27th Oct 201610:20 amRNSNine Months 2016 Results of PT Hero
14th Oct 201610:54 amRNSShares Purchase
13th Oct 201611:44 amRNSShares Purchase
12th Oct 20161:05 pmRNSDirector/PDMR Shareholding
12th Oct 201612:29 pmRNSTransaction in Own Shares
6th Oct 201610:24 amRNSAdditional Listing
30th Sep 201611:14 amRNSDirector Declaration
28th Sep 201610:24 amRNSDividend
26th Sep 201610:11 amRNSDividend
1st Sep 201610:37 amRNSDirector Declaration
31st Aug 201611:27 amRNSTotal Voting Rights
31st Aug 201610:09 amRNSCirc re. Scrip Dividend Scheme
22nd Aug 201610:25 amRNSDirector Declaration
10th Aug 201612:46 pmRNSDairy Farm Completes Fur Inv In Yonghui Superstore
5th Aug 201611:11 amRNSTransaction in Own Shares
4th Aug 201611:22 amRNSTransaction in Own Shares
3rd Aug 201610:10 amRNSDirector Declaration
1st Aug 201610:54 amRNSAstra, JC&C 2016 HY Results Ann. - Correction
1st Aug 201610:52 amRNSDirector Declaration
29th Jul 201610:49 amRNSJC&C - 2016 Half Year Financial Statements
29th Jul 201610:48 amRNSHalf Yearly Results - 6 Months Ended 30 June 2016
29th Jul 201610:48 amRNSHalf Yearly Results - 6 Months Ended 30 June 2016
28th Jul 201610:56 amRNSPT Astra - 2016 First Half Financial Statements
28th Jul 201610:09 amRNSHalf Yearly Results - 6 Months Ended 30 June 2016
28th Jul 201610:08 amRNSHalf Yearly Results - 6 Months ended 30 June 2016
27th Jul 201610:25 amRNSFirst Half 2016 Results of PT Hero
30th Jun 201610:32 amRNSTotal Voting Rights
30th Jun 201610:26 amRNSNotice of 2016 Half-Yearly Results
27th Jun 201611:49 amRNSTransaction in Own Shares
24th Jun 201612:12 pmRNSTransaction in Own Shares
22nd Jun 201611:02 amRNSTransaction in Own Shares
21st Jun 201611:19 amRNSTransaction in Own Shares
20th Jun 201611:22 amRNSTransaction in Own Shares
17th Jun 201611:15 amRNSTransaction in Own Shares
16th Jun 201611:42 amRNSTransaction in Own Shares
15th Jun 201610:51 amRNSTransaction in Own Shares
14th Jun 201611:19 amRNSTransaction in Own Shares
13th Jun 201611:16 amRNSTransaction in Own Shares
13th Jun 201610:11 amRNSDirectorate
10th Jun 201610:42 amRNSTransaction in Own Shares
8th Jun 201611:30 amRNSTransaction in Own Shares
7th Jun 201611:31 amRNSTransaction in Own Shares
6th Jun 201612:25 pmRNSTransaction in Own Shares
3rd Jun 201610:43 amRNSTransaction in Own Shares
3rd Jun 201610:42 amRNSDirector/PDMR Shareholding
31st May 201611:05 amRNSTotal Voting Rights
31st May 20167:21 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.